This content is machine translated Ankylosing spondylitis Therapy progress with JAKi and earlier diagnosis The treatment of ankylosing spondylitis (AS) is primarily aimed at using anti-inflammatory medication to relieve pain and prevent the development of ankylosis [1]. In this interview, Prof. Dr. Denis Poddubnyy…
View Post 5 min This content is machine translated Atopic dermatitis Achieving high treatment goals with the Minimal Disease Activity concept Patients with moderate to severe atopic dermatitis suffer from the physical and psychological effects of the disease and yet do not receive adequate treatment with systemic therapies, or often only…
View Post 9 min This content is machine translated Sponsored Content: Olfactory dysfunction Options against the loss of smell The sense of smell plays an important role in everyday life: it warns us of sometimes life-threatening dangers such as spoiled food, smoke or fires as well as toxins. This…
View Post 2 min This content is machine translated Webcast Dr. Braun & Prof. Marzolini COVID-19 in everyday practice: the treatment option with PAXLOVID®. Antiviral medications may be used in COVID-19 patient:s at increased risk for severe disease progression.1, 2 The antiviral PAXLOVID® (nirmatrelvir [PF-07321332] / ritonavir) is the only oral COVID-19 therapy approved…
View Post 2 min This content is machine translated Patient case Breast carcinoma with disseminated osteoblastic metastasis. More than 70% of breast cancer sufferers are diagnosed as hormone receptor positive and HER2 negative (HR+/HER2-) [1]. Clinical trial data show that a therapy combination with CDK4/6 inhibitors can…
View Post 1 min This content is machine translated Acute myeloid leukemia Therapy – if intensive chemotherapy is not possible AML predominantly affects older individuals, who are often not suitable for intensive chemotherapy due to their age and pre-existing conditions. Younger patients may also be ineligible for intensive chemotherapy due…
View Post 7 min This content is machine translated Medicalonline Long-term data on upadacitinib show a consistent safety profile and no new safety signals [1]. * With the exception of the already known higher herpes zoster and NMSC events and higher CPK levels.
View Post 9 min This content is machine translated Sponsored Content: PARKINSON DISEASE (PD) Tailored therapy for motor fluctuations At the EAN Congress 2022, a Bial satellite symposium discussed treatment options for motor fluctuations and presented new data on the pharmacokinetics of levodopa in combination with the COMT inhibitor…
View Post 6 min This content is machine translated Locally advanced or metastatic urothelial carcinoma Subgroup analyses of the JAVELIN Bladder 100 study – In the context of clinical practice. First-line chemotherapy followed by avelumab (BAVENCIO®)-maintenance therapy is the standard of care for patients with locally advanced or metastatic urothelial carcinoma who have not progressed on platinum-based chemotherapy, according to…
View Post 1 min This content is machine translated Swiss Oncology in Motion Module Urothelial Carcinoma Oncology is constantly changing, with additional diagnostic procedures, new surgical methods and innovative therapeutic concepts being developed. For this reason, the treatment guidelines are also continuously revised. This also applies… CME-Test
View Post 5 min This content is machine translated Interview with Natalie Marcoli, MD “Personalized treatment in rheumatology would help even more patients achieve remission.” Achieving remission is the ultimate goal in the treatment of the inflammatory rheumatic diseases rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis [1-3]. In the following interview, Natalie Marcoli, MD, from…
